Strattera is a medication used to treat attention deficit hyperactivity disorder (ADHD). It works by increasing levels of norepinephrine in the brain. This helps to increase attention and focus, which can improve the ability to get and keep an adequate amount of sleep. The drug comes in a box that you can place under the tongue, known as a gum.
The drug comes in two forms. The active form is called Strattera, which is a combination of two medications:
Atomoxetine:The active ingredient in Atomoxetine, Strattera, belongs to the class of antidepressants.
Cymbalta:A type of drug known as a dopamine reuptake inhibitor (DRI). It increases levels of norepinephrine and dopamine in the brain.
Strattera comes in two dosages:
Initial Dosage: 1-2 mg in the morning, preferably at bedtime.
Maintenance Dosage: 4 mg to 8 mg daily, depending on the medication’s effectiveness and side effects.
The effect of Strattera starts working within 15 to 30 minutes after you take it. The onset of action can vary depending on the type and severity of the condition. Strattera usually starts to work within about 30 minutes after you start taking it, but it can take up to several weeks for some individuals to notice full benefit. Some individuals may experience a significant improvement in their symptoms within a few days of starting the medication. It is important to talk with your healthcare provider to determine if Strattera is the right treatment option for you, as it may not be the right choice for everyone. Here are some general guidelines for using Strattera:
Titration: Use the provided dose to minimize the risk of overdose.
Dosage Adjustments: If you are concerned about the dosage adjustment, see your healthcare provider.
While Strattera is generally well-tolerated, it is important to be aware of potential side effects that may occur with the use of this medication:
Drowsiness: Some individuals may experience dizziness or drowsiness when taking Strattera.
Headaches: Some individuals may experience headaches when taking Strattera.
Nausea and Vomiting: Some individuals may experience nausea and vomiting when taking Strattera.
Constipation: Some individuals may experience constipation when taking Strattera.
Dizziness and Indigestion: Some individuals may experience dizziness or confusion when taking Strattera.
Dry mouth: Some individuals may experience dry mouth or difficulty in swallowing. This may result in weight gain.
Dry vision: Some individuals may experience blurred vision when taking Strattera.
Dry hearing: Some individuals may experience difficulty in hearing voices when taking Strattera.
Muscle weakness: Some individuals may experience muscle weakness when taking Strattera.
The duration of Strattera’s effects can vary depending on the individual, but some individuals may notice effects within an hour of starting the medication. However, it is important to note that the effects typically last 4 to 6 hours.
The effects of Strattera generally last between 4 to 6 hours.
Sold and Supplied by Healthylife Pharmacy
Atreats sudden and serious panic attacks and anxiety symptoms. Can be taken during or up to one hour after a stressful situation.
Atreats rapid weight gain, is highly effective in treating weight gain and excess fat in adults. It works by helping the heart to pump more blood around the body, causing weight loss.
Atreats seizures, fits, and panic attacks associated with bipolar disorder. Can be used during pregnancy and breast-feeding. Not intended for children.
Atreats ringing in the ears, confusion, and frequent or severe headaches. Can be used with other medications for anxiety and panic disorder.
Atreats ringing in the nose, weakness, and nausea.
Atreats sudden numbness or weakness, seizures, and confusion. Can be used with medications for multiple sclerosis or deep brain or spinal cord injuries.
Atreats ringing in the ears, weakness, and nausea.
Severely impaired liver function. Seizures and epilepsy are caused by excessive levels of norepinephrine in the brain, which prevents the re-growth of certain cells in the brain. This leads to seizures, fits, and coma.
Do not use if you have been diagnosed with a serious mental illness, are allergic to any medication, are older than 70 years of age, or have certain medical conditions. Do not take Atreats if you are taking any of the following medications:
Atreats sudden and serious seizures and epilepsy. Symptoms may include:
If you experience any of the following symptoms within 2 weeks of stopping Atreats:
If you experience any side effects such as headaches, dizziness, tiredness, nausea, vomiting, or muscle weakness, call your doctor immediately or get medical attention right away.
LONDON (AP) — A clinical trial found the most effective treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) was stimulant medication, but it didn’t work for the treatment of narcolepsy.
The trial, led by the drugmaker Eli Lilly, was a randomized double-blind controlled trial of a combination of atomoxetine, a selective norepinephrine reuptake inhibitor, and stimulant medication, and a nonstimulant drug, methylphenidate, in the treatment of ADHD.
ADHD is a neurodevelopmental disorder that affects about 1 in 10 people with the disorder. It is characterized by repeated and severe hyperactivity, repetitive behaviors, and poor social performance.
Researchers at the University of Texas Southwestern Medical Center in Dallas found that the stimulant drug methylphenidate reduced symptoms of ADHD by 80 percent. The medication was shown to be effective in treating ADHD symptoms, as well as improving social and educational outcomes.
The trial was led by Eli Lilly, which said it would continue with the trial.
The researchers said the stimulant drug was effective in treating ADHD symptoms in 70 percent of patients. But the study was small and short, so it wasn’t long enough to show the benefits of the treatment.
The trial was halted because of concerns about potential side effects, including suicidal thoughts. The Food and Drug Administration said it would allow the company to continue with the trial, although it would have to conduct another safety and effectiveness study to determine the long-term effects on children.
The stimulant was not approved for use in children under 12 years old.
“This trial demonstrated the safety and efficacy of a new, longer-acting, non-stimulant treatment for ADHD in children and adolescents,” said Dr. Steven E. Johnson, the clinical director of the National Institute on Child Health and Adhd. “We’re excited about this trial and believe it will be an important addition to the current treatment.”
In addition, Johnson said, the stimulant is used in children who have difficulty with social and academic performance.
“We have seen a very low prevalence of ADHD in children and adolescents,” he said. “We think that this trial will give us some additional information about the effectiveness of non-stimulant ADHD treatment for children and adolescents who need it.”
The stimulant is a type of drug that acts on the brain to improve the development of new norepinephrine and dopamine receptors, which play a role in learning and social skills.
The drug is sold under a variety of brand names, including Strattera, Methylphenidate, Adderall, Ritalin, Concerta, and Vyvanse.
It works by inhibiting the reuptake of norepinephrine in the brain.
“This is the first trial that we have evaluating the efficacy and safety of non-stimulant ADHD treatment for children and adolescents,” said Dr. Mark W. Thompson, a neuropsychiatrist at the Northwestern Memorial Hospital in Chicago who has served as clinical investigator for the trial.
“We believe it’s a significant step forward in improving children’s academic performance,” said Dr. Robert J. D’Amelio, director of the Institute for Clinical Development in Washington, D. C. “We also believe that non-stimulant ADHD treatment could provide a new treatment for children who do not respond to stimulant medication.”
The trial was part of a large study that included more than 3,800 children, including parents of children with ADHD who have been diagnosed with a disorder.
Because the ADHD diagnosis was made by a child’s teacher, the researchers used a technique known as teachers’ training, which was done by professionals who are trained to teach children about the disorder.
The teacher training was done by psychiatrists and neuropsychologists in a variety of academic settings.
Researchers also used a technique known as a transcranial magnetic stimulation (TMS) technique, which is used to stimulate neurons in the brain. The researchers studied the brain of children with ADHD, and found that methylphenidate reduced their symptoms of ADHD by up to 80 percent compared to placebo.
The trial is the first in a series of studies, which were published in the Journal of the American Medical Association.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$13.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Referrals & rejectalsiciary: You have received this or any other prescription medicine, including medicines obtained without a prescription, from a pharmacy or supermarket for your use only.
PharmacyMedicine Listing Information: This website offers generic medicine information, however, due to the strict language of the U. S. Food and Drug Administration's (FDA's) Medication Complianceisbury program, none of this information is absolute. This means that you will have to navigate the list of medications on the ''migdirectand search for 'generic medicine list'.
Patient Information : This medicine information website provides a variety of patient information, including medical history, current medications, and potential drug interactions, which are invaluable when you begin toraxure a new treatment. You will have a full and accurate complete list of all your medications, including any supplements, herbal remedies or vitamin d-containing products. You should not take this medication if you are allergic to any medicine or if you have ever had any medical conditions or disease.
Product Information : Product information can be found in the Product Information section of the website or in the Patient Information section of the website.
Product Label Information: This medicine information website provides a variety of patient information, including medical history, current medications, and potential drug interactions, which are invaluable when you begin toraxure a new treatment.Product Information : This medicine information website provides a variety of patient information, including medical history, current medications, and potential drug interactions, which are invaluable when you begin toraxure a new treatment.
Stade de France Pharmacy